Germany's network of 93 statutory health insurance funds reported a combined surplus of €2.6 billion during the first six months of 2026, a figure that on the surface might suggest the system is back on solid financial footing. But officials and analysts warn that the positive balance sheet masks a deeper structural problem: spending is rising far faster than the contributions that fund the system, and the surplus exists only because insurers raised premiums at the start of t

The Food and Drug Administration granted accelerated approval to Etcamah, known scientifically as camizestrant, for use alongside any of three widely used CDK4/6 inhibitors in adult patients whose tumors carry a particular genetic change called an ESR1 mutation. Why This Approval Matters Breast cancer remains the most frequently diagnosed malignancy among women in the United States, with more than 300,000 new cases identified each year and over 42,000 deaths. The majority of